Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol
2004 ◽
Vol 82
(5)
◽
pp. 1323-1329
◽
2009 ◽
Vol 92
(3)
◽
pp. S168
◽
2009 ◽
Vol 91
(6)
◽
pp. 2616-2619
◽
2020 ◽
Vol 114
(3)
◽
pp. 545-551
◽
2010 ◽
Vol 94
(5)
◽
pp. 1827-1831
◽
2013 ◽
Vol 100
(2)
◽
pp. 585-592.e1
◽
2007 ◽
Vol 6
(1)
◽
pp. 27-32
◽
2012 ◽
Vol 119
◽
pp. S439-S439